𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of human erythrocyte and plasma cholinesterases by methamidophos

✍ Scribed by Casey P. Robinson; Donald Beiergrohslein


Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
150 KB
Volume
2
Category
Article
ISSN
0260-437X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Methamidophos (O, S‐dimethyl phosphoramidothioate) inhibition of human erythrocyte and plasma cholinesterase was studied in vitro. The pseudo‐biomolecular rate constant of inhibition was 3.14 Β± 0.22 Γ— 10^3^ M^βˆ’1^ min^βˆ’1^ for erythrocyte cholinesterase and 1.85 Β± 0.01 Γ— 10^3^ M^βˆ’1^ min^βˆ’1^ for plasma cholinesterase. Thus methamidophos, although quite toxic to mammals, is a slow, rather non‐selective inhibitor of human cholinesterases, as was also observed previously in rats.


πŸ“œ SIMILAR VOLUMES


In vitro protection of plasma cholineste
✍ G. Petroianu; F. KΓΌhn; C. Thyes; V. Ewald; A. Missler πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 107 KB

## Abstract Metoclopramide (MCP) is a dopamine receptor antagonist and serotonine receptor agonist widely used as an antiemetic and gastric prokinetic drug. In addition MCP is a reversible inhibitor of cholinesterases from human central nervous system and blood. MCP may have a cholinesterase protec

In vitro protection of plasma cholineste
✍ G. Petroianu; F. KΓΌhn; K. Arafat; K. Zuleger; A. Missler πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 90 KB

## Abstract Metoclopramide (MCP) is a dopamine receptor antagonist and serotonin receptor agonist widely used as an antiemetic and gastric prokinetic drug. In addition MCP is a reversible inhibitor of cholinesterases from human central nervous system and blood. Metoclopramide may have a cholinester

Stereoselectivity of cholinesterase inhi
✍ T. Thomsen; U. Bickel; J. P. Fischer; H. Kewitz πŸ“‚ Article πŸ“… 1990 πŸ› Springer 🌐 English βš– 252 KB

The effect of galanthamine (GAL) and its 2 major metabolites on human cholinesterases has been explored. Epigalanthamine, a diastereomer of GAL, was 130-times less potent in vitro in its effect on acetylcholinesterase (AChE) in erythrocytes than the parent compound, and it did not differ significant